Uffe Bernchou

Uffe Bernchou

Auto-generated profile, based on publicly available information

Uffe Bernchou

Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital, Odense, Denmark

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2019 in Acta Oncologica
Verified
Journal Article
Closed access
ABAnders S. Bertelsen
Anders S. Bertelsen
TSTine Schytte
Tine Schytte
PMPia K. Møller
Pia K. Møller
FMFaisal Mahmood
Faisal Mahmood
HRHans L. Riis
Hans L. Riis
UBUffe Bernchou
Uffe Bernchou
Purpose: A 1.5 T MR Linac (MRL) has recently become available. MRL treatment workflows (WF) include online plan adaptation based on daily MR images (MRI). This study reports initial clinical experiences after five months of use in terms of patient compliance, cases, WF timings, and dosimetric accuracy. Method and materials: Two different WF were used dependent on the clinical situation of the day; Adapt To Position WF (ATP) where the reference plan position is adjusted rigidly to match the position of the targets and the OARs, and Adapt To Shape WF (ATS), where a new plan is created to match the anatomy of the day, using deformable image registration. Both WFs included three 3D MRI scans for plan adaptation, verification before beam on, and validation during IMRT delivery. Patient compliance and WF timings were recorded. Accuracy in dose delivery was assessed using a cylindrical diode phantom. Results: Nineteen patients have completed their treatment receiving a total of 176 fractions. Cases vary from prostate treatments (60Gy/20F) to SBRT treatments of lymph nodes (45 Gy/3F) and castration by ovarian irradiation (15 Gy/3F). The median session time (patient in to patient out) for 127 ATPs was 26 (21–78) min, four fractions lasted more than 45 min due to additional plan adaptation. For the 49 ATSs a median time of 12 (1–24) min was used for contouring resulting in a total median session time of 42 (29–91) min. Three SBRT fractions lasted more than an hour. The time on the MRL couch was well tolerated by the patients. The median gamma pass rate (2 mm,2% global max) for the adapted plans was 99.2 (93.4–100)%, showing good agreement between planned and delivered dose. Conclusion: MRL treatments, including daily MRIs, plan adaptation, and accurate dose delivery, are possible within a clinically acceptable timeframe and well tolerated by the patients.

24 August 2009 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
UBUffe Bernchou
Uffe Bernchou
JBJonathan Richard Brewer
Jonathan Richard Brewer
HMHenrik Skov Midtiby
Henrik Skov Midtiby
JIJohn. H. Ipsen
John. H. Ipsen
LBLuis A. Bagatolli
Luis A. Bagatolli
ASAdam C. Simonsen
Adam C. Simonsen

28 June 2006 in Journal of Physics: Condensed Matter
Verified
Journal Article
Closed access
OMOle G. Mouritsen
Ole G. Mouritsen
TAThomas L Andresen
Thomas L Andresen
AHAvi Halperin
Avi Halperin
PHPer Lyngs Hansen
Per Lyngs Hansen
AJAsk F Jakobsen
Ask F Jakobsen
MWMatthias Weiss
Matthias Weiss
A host of water-soluble enzymes are active at membrane surfaces and in association with membranes. Some of these enzymes are involved in signalling and in modification and remodelling of the membranes. A special class of enzymes, the phospholipases, and in particular secretory phospholipase A(2) (sPLA(2)), are only activated at the interface between water and membrane surfaces, where they lead to a break-down of the lipid molecules into lysolipids and free fatty acids. The activation is critically dependent on the physical properties of the lipid-membrane substrate. A topical review is given of our current understanding of the physical mechanisms responsible for activation of sPLA(2) as derived from a range of different experimental and theoretical investigations.

1 July 2014 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
CBCarsten Brink
Carsten Brink
UBUffe Bernchou
Uffe Bernchou
ABAnders Bertelsen
Anders Bertelsen
OHOlfred Hansen
Olfred Hansen
TSTine Schytte
Tine Schytte
SBSoren Bentzen
Soren Bentzen


1 October 2013 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
UBUffe Bernchou
Uffe Bernchou
TSTine Schytte
Tine Schytte
ABAnders Bertelsen
Anders Bertelsen
SBSoren Bentzen
Soren Bentzen
OHOlfred Hansen
Olfred Hansen
CBCarsten Brink
Carsten Brink